Clinical Trials Browser

Phase 2 × Risk Reduction Behavior × Estrogens, Conjugated (USP) × Clear all

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Phase 2 Active not recruiting

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior